Filament Health Corp. (NEO:FH)

Filament Health Statistics

Total Valuation

Filament Health has a market cap or net worth of CAD 36,786. The enterprise value is -172,053.

Market Cap	36,786
Enterprise Value	-172,053

Important Dates

The next estimated earnings date is Monday, November 10, 2025.

Earnings Date	Nov 10, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	261.79M
Shares Outstanding	n/a
Shares Change (YoY)	+25.20%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	38.15%
Owned by Institutions (%)	n/a
Float	110.68M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.08
PB Ratio	0.03
P/TBV Ratio	0.06
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	0.04
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	0.12

Financial Position

The company has a current ratio of 0.45, with a Debt / Equity ratio of 0.45.

Current Ratio	0.45
Quick Ratio	0.44
Debt / Equity	0.45
Debt / EBITDA	n/a
Debt / FCF	-0.33
Interest Coverage	-34.90

Financial Efficiency

Return on equity (ROE) is -208.81% and return on invested capital (ROIC) is -82.27%.

Return on Equity (ROE)	-208.81%
Return on Assets (ROA)	-52.80%
Return on Invested Capital (ROIC)	-82.27%
Return on Capital Employed (ROCE)	-240.01%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	13
Asset Turnover	0.12
Inventory Turnover	n/a

Taxes

Income Tax	-12,173
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -81.82% in the last 52 weeks. The beta is 0.91, so Filament Health's price volatility has been similar to the market average.

Beta (5Y)	0.91
52-Week Price Change	-81.82%
50-Day Moving Average	0.02
200-Day Moving Average	0.03
Relative Strength Index (RSI)	38.54
Average Volume (20 Days)	212,706

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Filament Health had revenue of CAD 468,051 and -4.44 million in losses. Loss per share was -0.02.

Revenue	468,051
Gross Profit	468,051
Operating Income	-3.34M
Pretax Income	-4.45M
Net Income	-4.44M
EBITDA	-3.33M
EBIT	-3.34M
Loss Per Share	-0.02

Balance Sheet

The company has 679,972 in cash and 477,276 in debt, giving a net cash position of 202,696.

Cash & Cash Equivalents	679,972
Total Debt	477,276
Net Cash	202,696
Net Cash Per Share	n/a
Equity (Book Value)	1.07M
Book Value Per Share	0.00
Working Capital	-987,869

Cash Flow

In the last 12 months, operating cash flow was -1.45 million and capital expenditures -13,729, giving a free cash flow of -1.46 million.

Operating Cash Flow	-1.45M
Capital Expenditures	-13,729
Free Cash Flow	-1.46M
FCF Per Share	n/a

Margins

Gross Margin	100.00%
Operating Margin	-712.94%
Pretax Margin	-951.30%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Filament Health does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-25.20%
Shareholder Yield	-25.20%
Earnings Yield	-12,070.79%
FCF Yield	-3,976.06%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Filament Health has an Altman Z-Score of -17.29 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-17.29
Piotroski F-Score	1